Abstract We applied a competitive enzyme-linked immunosorbent assay for the detection of antibodies for influenza A in equine sera to their detection in sera from wild aquatic birds. Suboptimal results were obtained for the optical density (OD) of the monoclonal antibody (MAb) control and reproducibility between duplicate analyses in the initial assessment. It was therefore necessary to modify the assay to deliver increased reliability and reproducibility while maintaining adequate sensitivity. We optimized reagent concentrations to obtain optimal OD values (close to 2) for the monoclonal antibody control and used 2, 2 0 -Azino-bis: 3-Benzthiazoline-6-Sulphonic Acid as an alternative chromogen to potentially reduce variability in duplicate analyses. The original assay was compared with the optimized versions, with and without post coating, for the detection of avian influenza viral antibodies in 240 sera obtained from wild plumed whistling ducks. A separate analytical sensitivity study on diluted positive field sera of plumed whistling ducks and a test of antigen stability after post coating were also performed. Some quantitative differences were detected between the original and modified assays. The original assay recorded higher percentage inhibition results which were potentially indicative of increased sensitivity. However, when reagent concentrations were increased in the original assay to the same levels as used in the modified versions, there were no quantitative differences for practical purposes. The original assay produced a median (OD) value of 0.81 for the (MAb) controls that is at the limit of acceptability. By contrast, the modified assays always produced acceptable optical density values for MAb controls. Our overall results indicated the modified assays were potentially more reliable (OD values close to 2), and of adequate sensitivity compared to the original assay in the detection of avian influenza viral antibodies in wild bird sera. Although further optimization of antigen and MAb concentrations should also be considered to increase the sensitivity of a modified assay, while maintaining acceptable optical density values for the MAb control. Post coating had a minimal quantitative effect on the results and stabilized the plates for 214 days. We therefore recommend the incorporation of post coating.
Introduction
Indirect enzyme linked immuno-sorbent assays (iELISAs) were the first technique to detect avian influenza viral (AIV) antibodies in poultry flocks [1, 2, 10] . The iELISA M. A. Hoque Á G. W. Burgessrequires species-specific conjugated antibodies; therefore a different conjugated antibody is needed for each host species tested. Competitive ELISAs (cELISAs) are not species-specific like iELISAs because the secondary antibody is specific for the MAb used, regardless of the species being tested [4, 8, 12] . In regards to other tests used to detect AIV antibodies, a cELISA was more sensitive and specific than the agar gel immuno diffusion (AGID) test [4, 9] , and as or more sensitive and specific as the haemagglutination inhibition (HI) test [3, 4, 9, 12] . A cELISA was also able to detect antibodies at an earlier stage of infection compared with the AGID and HI tests [5, 7, 11, 13] . Therefore, cELISAs are useful multi species diagnostic tests.
The Australian Animal Health Laboratory (AAHL) developed a cELISA (designated here as AAHL-1) in order to detect equine influenza viral antibodies from horse sera in Australia [8] . The equine influenza virus is of avian origin (H3 subtype) and its nucleoprotein (NP) is conserved across the Type A influenza viruses. The MAb raised against the NP in the AAHL-1 test is in the conserved region and therefore will detect other Type A influenza viruses. For this reason the assay was adopted for the detection of AIV antibodies in chickens, followed by wild bird sera, in Australia although the ability of the test to detect AIV antibodies in bird sera had not been rigorously assessed or published.
AAHL provided its protocol (AAHL-1) and necessary reagents to screen AIV antibodies in serum samples from wild aquatic birds (WABs) in our large AI surveillance program in northern Queensland, Australia. As a starting point, we used the AAHL-1 test without any modification to screen AIV antibodies from 411 field serum samples from WABs and observed low and variable optical density (OD) values for the MAb control. In some instances, the OD values for the MAb did not meet the minimum quality control OD value of 0.8 [8] . It was demonstrated that the concentrations of the AIV antigen, MAb and conjugate as described by Selleck [8] were suboptimal and responsible for the low OD of the MAb.
In addition, the variation in percentage inhibition between duplicate wells exceeded ±10 % which also did not meet quality guidelines [8] . The use of 3, 3 0 5, 5 0 -Tetramethylbenzidine (TMB) as a chromogen with a short incubation period (e.g., 5 min in AAHL-1) can increase background noise, variability between duplicate analyses and the possible generation of false positive or negative results.
It was therefore necessary to modify the assay to ensure adequate sensitivity and reliability for the analysis of all samples collected in our AI surveillance program. We optimized reagent concentrations to obtain optimal OD values (close to 2) for the MAb control (this was done by doubling the recommended reagent concentrations, data not shown) and used 2, 2 0 -Azino-bis: 3-Benzthiazoline-6-sulphonic acid (ABTS) as an alternative chromogen to potentially increase reliability. The chromogen ABTS has slower color development and less background staining potentially reducing variability. We also included an additional step of using post coating to have more stable AIV antigen in plates with the aim of avoiding non specific results and facilitating long term storage and reducing between-run variability.
In order to assess the effects of these modifications on the sensitivity and reliability of AIV antibody detection and to ensure that the modified assays were suitable for use in our study, we compared the AAHL-1 [8] technique with the modified assay, with and without post coating (referred to as James Cook University-1) (JCU-1 and JCU-2, respectively). For this comparison, we analysed 240 sera obtained from wild plumed whistling ducks (PWDs) (Dendrocygna eytoni). We concurrently compared the three assays with the AAHL-1 technique but using double the recommended reagent dilutions (now indicated as AAHL-2).
A separate study for the four assays (AAHl-1 and 2 and JCU-1 and 2) was performed on diluted positive field PWD sera to compare analytical sensitivity. The longitudinal stability of the AIV antigen following post-coating was assessed to determine if storage of large batches of plates was feasible in order to make the test more efficient and obtain more consistent results between sample batches. To summarize our aims are to assess the AAHL-1 cELISA for detecting AIV antibodies in wild bird sera and to determine whether our modifications affect reliability and sensitivity.
Materials and Methods

Sera
Plumed whistling ducks were caught from December 2007 to December 2009 at Billabong Sanctuary and Green Acres Lagoon, located south of Townsville, north Queensland, Australia. Whole blood samples (0.5-3 ml, \1 % of body weight) were drawn aseptically from wing veins. The samples were transferred immediately to sterile 15 ml plastic tubes. Blood samples were refrigerated within 5 h of sampling. After over-night storage the samples were returned to air conditioned room temperature (22°C) before centrifugation at 317g for 10 min. Supernatant was decanted, transferred to a 1.5 ml microfuge tube and centrifuged at 2,348g for 2 min and stored at -20°C until analysed.
Competitive Enzyme-Linked Immuno Sorbent Assay Four cELISAs were assessed under an equivalence study that included AAHL-1 [8] and three modified versions designated as AAHL-2, JCU-1 and JCU-2. We used U-bottom microtitre plates instead of the AAHL suggested Nunc maxisorp plates and H 3 P0 4 (stop solution) in place of H 2 S0 4 for this study. Modifications are described under the procedure of cELISA below.
1. The recombinant AIV antigen (source-Paul Selleck, AAHL) was diluted at a rate of 1 in 800 (for AAHL-1) or 1 in 400 (for the AHHL-2 and JCU assays) in coating buffer (sodium bi-carbonate 3.11 mg, sodium carbonate 1.38 mg and distilled water 1,000 ml; source-TropBio Pty Ltd, JCU) and 50 ll was loaded into each well of a round (U) bottom 96-wellmicrotitre plate. The plate was covered and incubated overnight at 4°C for AAHL-1, AAHL-2 and JCU-1 and in a sealed humidified box for JCU-2. 2. One of the following steps was then followed: for the AAHL-1 and 2 and JCU-1 assays, the diluted coating buffer was removed and the wells were washed using wash buffer (Tris-technical grade-MP Biomedicals, sodium chloride-AR grade (Crown scientific), di-sodium salt-EDTA-AR grade, Pronelis, tween 20 (Sigma); Source-TropBio) with the aid of a squeeze bottle. Washing consisted of 4, 5-s rinses, with complete emptying of wells between rinses. After washing, the plate was inverted and tapped on a paper towel to remove any residual wash buffer. The plates were covered with lids immediately after washing to prevent drying; for the JCU-2, the diluted coating buffer was removed and 100 ll of post coating buffer (Proprietary, TropBio, Cat. No. 05-004-05) was dispensed into each well and kept in a humid box for 2 h. After incubation, the residual coating buffer was removed and the plate was tap dried with a paper towel and incubated at 37°C for 2 h. 3. Each test serum was diluted at a rate of 1 in 10 with serum diluent (Tris-MP Biomedicals, sodium chloride, di-sodium salt-EDTA, casein, tween 20, bromophenol blue-BioRad-1.0 % in TEN buffer, distilled water; source-TropBio). Dilutions were made in a 96-wells transfer plate to facilitate mixing. 4. AIV antibody positive-control chicken sera provided by AAHL (Source, Paul Selleck, AAHL) was diluted in serum diluents at a rate of 1 in 50 and 1 in 500, whereas the AIV antibody negative-control chicken sera provided by AAHL (Source, Paul Selleck, AAHL) and AIV negative sera collected from JCU reared chickens were diluted at 1 in 10.
5. For the equivalence study, test sera and controls (positive, negative and conjugate) were tested in duplicate, whereas four wells were used for the MAb control. Fifty ll of diluted test serum and all controls were transferred from the dilution plate to the antigen coated plate. The plate was covered immediately with a lid and incubated at room temperature (22°C) for an hour. 6. Nucleoprotein mouse MAb (Source, Paul Selleck, AAHL) was diluted at 1 in 800 (for AAHL-1) or 1 in 400 (for the AAHL-2 and JCU assays) in serum diluent and 50 ll added to all wells immediately after the serum incubation step except for the wells specified for the conjugate control wells. The plate was covered and incubated for an hour at room temperature (22°C) and the plate was then washed as described in step 2. [6] where Z a , value of the standard normal distribution at specified level of confidence = 1.96 (2-tailed), Z b , power of the study = 1.28 (2-tailed), (Standard deviation, SD) 2 = the variance (0.02), d (permitted difference) = 0.04. Variance estimates were obtained from previous serology results. The permitted level of difference was ±10 % between wells within a plate [8] .
Therefore, we conservatively assumed ±4 % permitted difference between assays for sample size calculation.
Two hundred and forty serum samples were randomly selected from 500 samples that were initially screened by JCU-2 for the equivalence study comparing AAHL-1, JCU-1 and JCU-2. One hundred and sixty of the analysed serum samples were also concurrently tested using AAHL-2.
Analytical Sensitivity Study
Two pooled PWD sera samples were made to test the analytical sensitivity of assays AAHL-1 and 2 and JCU-1 and 2: one from 10 individual positive sera samples, each with 80-96 % inhibition and one from 10 individual negative sera samples, each with 10 % inhibition. The positive and negative sera were randomly selected from 15 positive and 120 negative sera as previously assessed by JCU-2. A pooled sera sample was then diluted at 1 in 10 with serum diluent before making a dilution series of each. We tested the following eight dilutions, based on the results of two small prior experiments: 1 is to 0 (positive: negative) (0 % dilution, undiluted positive pooled sera), 1 is to 0.5 (33 %, mixed positive-negative pool), 1 is to 1 (50 %), 1 is to 2 (67 %), 1 is to 3 (75 %), 1 is to 4 (80 %), 1 is to 8 (89 %) and 0 is to 1 (100 %, undiluted negative pooled sera).
We tested 10 replications per dilution using the four assays. For quality assurance, we included the AAHL positive chicken sera at the dilutions of 1 in 50, 1 in 500 and 1 in 5,000, each consisting of two replications, and negative sera at the dilution of 1 in 10 and 1 in 100, each consisting of one replication. In addition, we included four conjugate and four MAb controls. We used the first two columns (16 wells) for all the controls and the remaining 10 columns (80 wells) of U-bottom ELISA micro-titre plates for the analysis of the diluted sera. The sensitivity testing was performed concurrently for each assay.
The Longitudinal Effect of Post-Coating on AIV Antigen Stability in Plates
We prepared eight wells of 10 U-bottom microtitre plates, as previously described, and stored them at 4°C until testing. The plate coating was as described for the JCU-2 assay (step 1-2) . The test procedure was as described for the JCU-2 assay (step [6] [7] [8] 
Statistical Analysis
Equivalence Study
Data obtained were entered in the MS Excel-2003, coded and sorted and then exported into STATA TM 11.0 (Stata Corporation, College Station, TX) for analysis. Data were cross-checked for validity and consistency.
We defined an acceptable difference in percentage inhibition between wells within a plate as 10 %, as indicated by the AAHL [8] . The average percentage inhibition of an individual sample was calculated. For equivalence testing we calculated the mean difference in percentage inhibitions (MDPI) with their corresponding 95 % confidence intervals (CIs) between the assays. For the equivalence experiment (N = 240), we compared the results between the following paired assays: AAHL-1 versus JCU-1; AAHL-1 versus JCU-2; JCU-1 versus JCU-2. For a subset of the results (N = 160), we also compared all four tests including AAHL-2. The assays were considered equivalent when the 95 % CI of the difference in average inhibition was within ±5 %.
Categories of negative and positive for AIV antibodies were used as a binary response variable. Sera that produced \40 % inhibition were negative and sera that produced C40 % inhibition were positive [8] . In addition, a study has found that the % inhibition values for AIV antibody negative control sera ranged from 0 to 27 % using cELISA for a range of bird species, further supporting the need for a threshold of C40 % inhibition [12] . We constructed two by two tables comparing the number of positive and negative results obtained for each assay, in pair-wise comparisons.
McNemar tests were performed to compare the proportions of two discordant pairs in each table as a qualitative measure of equivalence. We expressed and interpreted the results as a difference between the discordant paired proportions with the p value and 95 % CIs.
We also compared the MAb control results between the assays using the Wilcoxon rank sum test (unpaired test) followed by a median test (unpaired test). The results were expressed as mean and median OD values with the p values.
Analytical Sensitivity Study
For the sensitivity study we tested a dilution series of pooled PWD sera. A descriptive statistic was carried out on the mean percentage inhibition in relation to different dilutions of serum samples and the results were presented in a line graph.
In the dilution series we had 0 % dilution (undiluted positive pooled sera), 33-89 % (mixed positive-negative sera) and 100 % (undiluted negative pooled sera). Therefore, we fitted three linear models. For the 0 % dilution, we performed the one-way-ANOVA (Model-A) on the mean percentage inhibition between assays. For the 33-89 % dilutions, we performed two-way-ANOVA (Model-B) on the mean percentage inhibition for the variables of assay and dilution factors. For the 100 % dilution, once again we used the one-way-ANOVA (Model-C) on mean percentage inhibition between assays.
Contrasts were carried out to determine the differences between cELISA types within each dilution of 0 and 100 % and to explain the interaction between dilutions (33-89 %) and ELISA types on mean percentage inhibition.
The Longitudinal Effect of a Post-Coating Buffer on AIV Antigen Stability in Plates
In the post-coating buffer experiment, the OD values of paired wells were used to calculate mean OD values. To test for differences in mean OD of the MAb, we used a one-way analysis of variance. The results were expressed as a mean, 95 % CI and p value.
Results
Equivalence Study
Mean Difference in Percentage Inhibition Between the Assays
The 95 % confidence limits (CIs) of the difference in percentage inhibition between the modified versions of cELISAs JCU 1 and 2 (N = 240) were 4.5-7.2 % (Table 1 ) and therefore it is ambiguous whether the assays are equivalent given that we regard a difference ±5 % as acceptable. The results for AAHL-1 and JCU-1 were similar having a 95 % CI of 4.8-6.8, therefore, also ambiguous with regard to equivalence. The CI for differences between the AAHL-1 assay and JCU-2 assay were greater than the allowable range of ±5 % (9.8-13.3 %) and the assays were therefore not quantitatively equivalent (Table 1) .
When only 160 samples were tested, incorporating the testing of AAHL-2, the data showed no quantitative difference between the AAHL-2 and JCU assays. The 95 % CIs were 1.2-3.8 for the AAHL-2 versus JCU-1; -0.02 to 0.5 for AAHL-2 versus JCU-2; 1.4-4.1 for JCU-1 versus JCU-2.
However, the CIs were higher than the acceptable limit ±5 % when we compared the results between the AAHL-1 and the other assays (5.6-8.9 for AAHL1 versus AAHL-2; 3.6-5.9 for AAHL-1 versus JCU-1 and 5.8-9.2 for AAHL-1 versus JCU-2).
Qualitative Analysis of Percentage Inhibition Between the Assays
Qualitative analysis of the results showed significant differences between AAHL-1 and JCU-1 and between AAHL-1 and JCU-2 assays, but no difference between the JCU assays based on the McNemar test (Table 2) (N = 240). However, the criterion for equivalence was again assumed to be within ±5 %, in this case the proportion of discordant pairs. Therefore, it was ambiguous whether AAHL-1 and JCU-1 and AAHL-1 and JCU-2 assays were equivalent as the 95 % CI of the differences overlapped with 5 %. When a subset of the samples was analysed, incorporating the testing of AAHL-2, the results showed no difference in the number of positive sera determined between all pair-wise comparisons except between AAHL-1 and JCU-1 (-0.06 to 0.01) which was again ambiguously equivalent at a 5 % level.
Comparison of Monoclonal Antibody Controls
The OD values obtained for the MAb controls differed significantly between the AAHL-1 and JCU-1 and the AAHL-1 and JCU-2, but there were no significant differences between the JCU assays (Table 3 ) (N = 240). When a subset of the samples were analysed (N = 160), incorporating the testing of AAHL-2, the OD values obtained for the MAb controls also differed significantly between the AAHL-1 and other assays, but were statistically equal between the AAHL-2 and JCU assays (Table 4) .
Analytical Sensitivity Study
Descriptive Results of Sensitivity Testing
The results of the mean percentage inhibition in relation to different dilution of serum samples are presented in Fig. 1 . The one-way-ANOVA testing between cELISA types for mean percentage inhibition values of the undiluted positive Table 2 The assessment of agreement between AAHL and JCU assays in the proportions of samples in the categories of C40 % inhibition (positive) and \40 % inhibition (negative) Number of sera in % inhibition categories as produced by the AAHL-1 assay OD optical density, AAHL Australian Animal Health Laboratory, JCU James Cook University, p probability value PWD sera showed significant differences among the assays (p \ 0.001). The predicted means (95 % CIs) for the assays were as follows: AAHL-1 95.6 % (94.1-97.2), AAHL-2 89.1 % (87.6-90.6), JCU-1 89.5 % (88-91.1) and JCU-2 90.2 % (88.7-91.7). Post hoc analysis showed that there was no significant difference between the AAHL-2, JCU-1 and the JCU-2 assays (p B 0.420). The AAHL-1 assay, however, produced a higher mean percentage inhibition for the pooled positive sera compared to the other assays (p \ 0.001).
Model-B Two-Way-ANOVA Testing on Mean Percentage Inhibition with 33-89 % Dilutions
The two-way-ANOVA testing on mean percentage inhibition for the variables of assay and dilution factor (33-89 %, mixed positive-negative pool) found a significant interaction effect between the cELISA types and the dilution factor (p = 0.018). The AAHL-2, JCU-1 and JCU-2 assays were not significantly different at 33, 80 and 89 % (p [ 0.05) dilutions, however, the AAHL-1 assay gave significantly higher percentage inhibitions than the other assays (p \ 0.001) at all dilutions (Table 5) .
The AAHL-2 and JCU-1 assays were not significantly different at 50, 67 and 75 % dilutions (p C 0.21), but the JCU-2 assay differed significantly from them (p B 0.04) at these dilutions. The AAHL-1 produced a significantly higher mean percentage inhibition than the other assays (Table 5) .
Model-C One-Way-ANOVA Testing on Mean Percentage Inhibition with 100 % Dilution (Undiluted Negative Pooled Sera)
The one-way-ANOVA testing on the mean percentage inhibition values of the undiluted negative PWD sera in different cELISA types showed significant differences between all assays (p \ 0.001). The predicted means (95 % CIs) were as follows: AAHL-1 11.5 % (9.2-13.8), AAHL-2 7.4 % (5.1-9.7), JCU-1 -3.4 % (-5.7 to -1.1) OD optical density, AAHL Australian Animal Health Laboratory, JCU Jame Cook University, p probability, vs. versus and JCU-2 2.5 % (0.2-4.9). Post hoc analysis also showed significant differences between the assays (p B 0.015).
The Longitudinal Effect of Post Coating Buffer on the Stability of AIV Antigen in Plates
Mean OD values for the MAb at 10 different points during a 214 day period in the post coating buffer experiment were as follows 1.8 (95 CI 1.6-1.9, Day 0), 1.9 (1.8-2.0, 1), 1.9 (1.9-2.0, 2), 1. 
Discussion
The AIV cELISAs used in this study did not perform equally in the quantitative detection of AIV antibodies in the sera of PWDs. Unequivocal differences were measured between AAHL-1 and JCU-2 where the AAHL-1 assay produced a higher mean % inhibition value in the analysis of 240 serum samples. Higher percentage inhibition values for AAHL-1 over the other assays were also evident in the sensitivity testing. The discrepancy of the results between the AAHL-1 and either of the JCU techniques corresponds to the use of different reagent dilutions (antigen, antibody and conjugate) along with the type of chromogen (TMB or ABTS) used in the assays. The JCU assays used reagent dilutions optimised for OD (close to 2) for the MAb control, having twice the concentration of antigen and MAb as the AAHL-1 assay. Reduced levels of antigen and MAb in the AAHL-1 procedure would increase the percentage inhibition values for a given serum sample in comparison to other assays by reducing the amount of MAb available to compete with antibodies in the test sera, thus increasing the difference in OD between the MAb control and that obtained for the test sera. The higher percentage inhibition values observed for AAHL-1 are probably indicative of increased sensitivity although the overall quality of the AAHL-1 cELISA can be considered in doubt due to unacceptable OD values (\0.8) for the MAb control [8] . We did not have adequate time and resources to test various combinations of reagent concentrations and chose to test modified versions having a single combination of reagent concentrations optimised for an OD of 2 for the MAb control.
The OD values for the MAb controls in the JCU assays were satisfactory (median OD close to 2). However, it appears that when the same reagent dilutions are used (AAHL-2) all three assays have equal performances for practical purposes. In regards to quantitative differences between the assays our sensitivity testing also showed a higher sensitivity for AAHL-1 assay over others but this assay once again failed to meet the test quality guideline of 0.8 OD value for MAb control (data are not presented here). Analytical sensitivity of the other assays (AAHL-2, JCU-1 and JCU-2) appeared to be identical with satisfactory OD values for the MAb controls ( Fig. 1; Table 5 ). Moreover, these modified assays showed an adequate relative sensitivity compared to AAHL-1 to detect AIV antibodies field sera for practical purposes as differences were not unambiguously more than 5 % ( Table 2) .
Our study to investigate the longitudinal effect of a post coating treatment on AIV antigens in cELISA plates demonstrated antigen stability in plates over a 214 day period. This result clearly indicated the benefit of using the post-coating buffer where a large number of plates can be prepared and stored, minimising variation between batches of plates. Therefore, the addition of the post coating step to cELISA appears to be beneficial.
In conclusion, our study is the first to improve the AAHL cELISA using wild bird sera in Australia. Further optimization of antigen and MAb concentrations should be considered to increase the sensitivity of a modified assay, compared to JCU-2, while maintaining acceptable OD values for the MAb control. In addition, the performance of these versions of cELISAs needs to be compared with commercially available cELISAs to determine their absolute and relative sensitivity and specificity.
